CHARLES KAYAT: Open Payments
NPI 1942556121 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 54 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $175 |
| ABBVIE INC. | 9 | $172 |
| AstraZeneca Pharmaceuticals LP | 7 | $171 |
| Novo Nordisk Inc | 5 | $99 |
| Astellas Pharma US Inc | 4 | $98 |
| Abbott Laboratories | 4 | $91 |
| Amgen Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $48 |
| Exact Sciences Corporation | 1 | $29 |
Products named: ELIQUIS, Veozah, FREESTYLE LIBRE 3, BREZTRI, AIRSUPRA, QULIPTA, EVENITY, VRAYLAR.
Industry payments across FL — which companies pay providers there.
